Prognostic role of multiple abnormal genes in non-small-cell lung cancer

BACKGROUND: Non-small-cell lung cancer (NSCLC) has the highest morbidity and mortality rates among all malignant tumor types. Although therapies targeting the mutated genes such as KRAS have been used in the clinic for many years, the prognosis remains poor. Therefore, it is necessary to further stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Lu-Da, Yang, Liu, Li, Na, Wang, Meng, Zhang, Yan-Hua, Zhou, Wen, Yu, Zhi-Qiong, Peng, Xiao-Chun, Cai, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372825/
https://www.ncbi.nlm.nih.gov/pubmed/36158484
http://dx.doi.org/10.12998/wjcc.v10.i22.7772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372825/
https://www.ncbi.nlm.nih.gov/pubmed/36158484
http://dx.doi.org/10.12998/wjcc.v10.i22.7772

Ejemplares similares